AXGN
Price
$10.41
Change
-$0.51 (-4.67%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
348.67M
58 days until earnings call
GMED
Price
$60.36
Change
+$0.44 (+0.73%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
7.19B
52 days until earnings call
Interact to see
Advertisement

AXGN vs GMED

Header iconAXGN vs GMED Comparison
Open Charts AXGN vs GMEDBanner chart's image
Axogen
Price$10.41
Change-$0.51 (-4.67%)
Volume$14K
Capitalization348.67M
Globus Medical
Price$60.36
Change+$0.44 (+0.73%)
Volume$11.69K
Capitalization7.19B
AXGN vs GMED Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. GMED commentary
Jun 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a StrongBuy and GMED is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2025
Stock price -- (AXGN: $10.96 vs. GMED: $59.21)
Brand notoriety: AXGN and GMED are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 80% vs. GMED: 59%
Market capitalization -- AXGN: $348.67M vs. GMED: $7.19B
AXGN [@Medical Specialties] is valued at $348.67M. GMED’s [@Medical Specialties] market capitalization is $7.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • GMED’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 5 TA indicator(s) are bullish while GMED’s TA Score has 5 bullish TA indicator(s).

  • AXGN’s TA Score: 5 bullish, 3 bearish.
  • GMED’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AXGN and GMED are a good buy in the short-term.

Price Growth

AXGN (@Medical Specialties) experienced а -3.82% price change this week, while GMED (@Medical Specialties) price change was -0.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.37%. For the same industry, the average monthly price growth was +5.59%, and the average quarterly price growth was +1.68%.

Reported Earning Dates

AXGN is expected to report earnings on Aug 06, 2025.

GMED is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+3.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.19B) has a higher market cap than AXGN($349M). GMED YTD gains are higher at: -28.413 vs. AXGN (-33.495). GMED has higher annual earnings (EBITDA): 347M vs. AXGN (-13.33M). GMED has more cash in the bank: 518M vs. AXGN (31M). AXGN has less debt than GMED: AXGN (69.3M) vs GMED (520M). GMED has higher revenues than AXGN: GMED (1.57B) vs AXGN (159M).
AXGNGMEDAXGN / GMED
Capitalization349M7.19B5%
EBITDA-13.33M347M-4%
Gain YTD-33.495-28.413118%
P/E RatioN/A49.65-
Revenue159M1.57B10%
Total Cash31M518M6%
Total Debt69.3M520M13%
FUNDAMENTALS RATINGS
AXGN vs GMED: Fundamental Ratings
AXGN
GMED
OUTLOOK RATING
1..100
5154
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
9172
SMR RATING
1..100
9387
PRICE GROWTH RATING
1..100
6487
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (44) in the Medical Specialties industry is somewhat better than the same rating for GMED (80). This means that AXGN’s stock grew somewhat faster than GMED’s over the last 12 months.

GMED's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as AXGN (91). This means that GMED’s stock grew similarly to AXGN’s over the last 12 months.

GMED's SMR Rating (87) in the Medical Specialties industry is in the same range as AXGN (93). This means that GMED’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (64) in the Medical Specialties industry is in the same range as GMED (87). This means that AXGN’s stock grew similarly to GMED’s over the last 12 months.

GMED's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as AXGN (100). This means that GMED’s stock grew similarly to AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNGMED
RSI
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 13 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 13 days ago
76%
Momentum
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 13 days ago
67%
MACD
ODDS (%)
Bearish Trend 13 days ago
72%
Bearish Trend 13 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 13 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 13 days ago
56%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
66%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 19 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 13 days ago
74%
Aroon
ODDS (%)
Bearish Trend 13 days ago
80%
Bearish Trend 13 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with VMD. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-3.01%
VMD - AXGN
44%
Loosely correlated
-0.45%
MXCT - AXGN
37%
Loosely correlated
-4.62%
XRAY - AXGN
33%
Poorly correlated
+1.04%
GMED - AXGN
33%
Poorly correlated
-0.64%
SERA - AXGN
32%
Poorly correlated
-1.79%
More

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.64%
VREX - GMED
49%
Loosely correlated
+0.38%
CTKB - GMED
47%
Loosely correlated
-3.11%
GKOS - GMED
42%
Loosely correlated
-2.07%
CVRX - GMED
42%
Loosely correlated
-3.02%
MMSI - GMED
40%
Loosely correlated
-2.15%
More